Literature DB >> 12531370

Adopting the pre-hospital index for interfacility helicopter transport: a proposal.

Leanelle Goldstein1, Christopher J Doig, Sarah Bates, Sandra Rink, John B Kortbeek.   

Abstract

BACKGROUND: Interfacility helicopter transport is expensive without proven outcome benefit in trauma patients. Our objectives were to determine the fastest method of rural to urban interfacility transport, and develop a triage tool to identify patients most in need of rapid transport.
METHODS: Retrospective cohort study. Adults ISS > or = 12 transported from January 1996 to December 1998. Transport time variables were compared between geographical zones. A pre-transport index (PTI) identified two patient cohorts in which outcome was assessed.
RESULTS: Air ambulance was faster than ground transport, with helicopter overall superior to fixed-wing (< 225 km range). Seventy-two percent of patients with PTI < 4 (n = 196) had no outcome indicating severe injury versus 29% of the PTI > or = 4 cohort (n=151). Mortality for PTI<4 was 1.4% versus 22% for PTI > or = 4.
CONCLUSION: Interfacility helicopter transport of severely injured rural trauma patients was the overall fastest method within a 225 km range. PTI > 4 identifies patients most in need of this fast but expensive method of transport.

Entities:  

Mesh:

Year:  2003        PMID: 12531370     DOI: 10.1016/s0020-1383(02)00082-7

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  2 in total

1.  Appropriate use of helicopters to transport trauma patients from incident scene to hospital in the United Kingdom: an algorithm.

Authors:  J J M Black; M E Ward; D J Lockey
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

2.  Helicopter emergency medical service in fars province: the referral trauma center of South of iran.

Authors:  M J Moradian; B Rastegarfar; R Salahi; H R Abbasi; Sh Paydar; M R Rastegar; M Dehghani; S Mousavi; E Shirzad; M Khorrami; M Esnaashar; Sh Bolandparvaz
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.